×
About 6,285 results

ALLMedicine™ Herpes Zoster Center

Research & Reviews  1,644 results

Risk of herpes zoster (shingles) in patients with rheumatoid arthritis under biologic, ...
https://doi.org/10.1136/annrheumdis-2021-220651
Annals of the Rheumatic Diseases; Redeker I, Albrecht K et. al.

Jul 30th, 2021 - To compare event and incidence rates of herpes zoster (HZ), also known as shingles, in patients with rheumatoid arthritis under treatment with conventional synthetic (cs), targeted synthetic (ts) or biologic (b) disease-modifying antirheumatic dru...

Association between cirrhosis and herpes zoster in a cohort study in Taiwan.
https://doi.org/10.1111/ijcp.14677
International Journal of Clinical Practice; Lai SW, Liao KF et. al.

Jul 30th, 2021 - The aim of the study was to assess if an association exists between cirrhosis and herpes zoster in Taiwan. A retrospective cohort study was designed to analyze the 2000-2013 claims dataset of 1 million insured residents who were randomly sampled f...

A practitioner's guide to the recombinant zoster vaccine: review of national vaccinatio...
https://doi.org/10.1080/14760584.2021.1956906
Expert Review of Vaccines; Parikh R, Widenmaier R et. al.

Jul 28th, 2021 - The adjuvanted recombinant zoster vaccine (RZV) is currently licensed in over 30 countries for the prevention of herpes zoster (HZ) in adults aged ≥50 years. We conducted a review of available national guidelines or recommendations on RZV use to i...

Development of Herpes Zoster Ophthalmicus in an Immunocompetent Pediatric Patient Follo...
https://doi.org/10.1097/IOP.0000000000001970
Ophthalmic Plastic and Reconstructive Surgery; Kamboj A, Hwang CJ et. al.

Jul 28th, 2021 - Herpes zoster ophthalmicus (HZO) is a neuro-oculo-dermic infection caused by reactivation of latent varicella zoster virus in the dorsal root ganglia of the ophthalmic division of the trigeminal nerve. Although a rare diagnosis in an otherwise hea...

see more →

Guidelines  3 results

Interventional management of neuropathic pain: NeuPSIG recommendations.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4484720
Pain References; Dworkin RH, O'Connor AB et. al.

Jun 12th, 2013 - Neuropathic pain (NP) is often refractory to pharmacologic and noninterventional treatment. On behalf of the International Association for the Study of Pain Neuropathic Pain Special Interest Group, the authors evaluated systematic reviews, clinica...

Vaccines for measles, mumps, rubella, varicella, and herpes zoster: immunization guidel...
https://www.ncbi.nlm.nih.gov/pubmed/22086887
The Journal of the American Osteopathic Association; Hendriksz T, Malouf P et. al.

Dec 7th, 2011 - Although vaccinations are most commonly associated with the pediatric population, it is important for healthcare professionals to be familiar with the vaccines that are recommended for adults. The authors discuss 3 vaccines-the measles, mumps, and...

Prevention of herpes zoster: recommendations of the Advisory Committee on Immunization ...
https://www.ncbi.nlm.nih.gov/pubmed/18528318
MMWR. Recommendations and Reports : Morbidity and Mortali... Harpaz R, Ortega-Sanchez IR et. al.

Jun 6th, 2008 - These recommendations represent the first statement by the Advisory Committee on Immunization Practices (ACIP) on the use of a live attenuated vaccine for the prevention of herpes zoster (zoster) (i.e., shingles) and its sequelae, which was licens...

see more →

Drugs  486 results see all →

Clinicaltrials.gov  58 results

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Participants Undergoing ...
https://clinicaltrials.gov/ct2/show/NCT01229267

Sep 30th, 2019 - Study participants were randomized to receive one of 3 consistency lots of V212, a high antigen lot of V212, or placebo. To comply with regulatory requests, results for all lots of V212 were combined for the primary and secondary efficacy and safe...

A Study to Evaluate the Safety and Efficacy of Inactivated Varicella-zoster Vaccine (VZV) as a Preventative Treatment for Herpes Zoster (HZ) and HZ-related Complications in Adult Participants With ...
https://clinicaltrials.gov/ct2/show/NCT01254630

Sep 30th, 2019 - This is a randomized, double-blind, placebo-controlled study to assess the safety and tolerability of V212 when administered to adults with solid tumor malignancy (STM) receiving chemotherapy and to assess the impact of V212 on the development of ...

MMF for HIV Reservoir Reduction
https://clinicaltrials.gov/ct2/show/NCT03262441

Sep 9th, 2019 - This is an open-label, randomized pilot trial to determine whether MMF given over 22 months meaningfully decreases the size of the HIV reservoir. At the University of Washington in Seattle, investigators will enroll 5 study participants who have b...

Safety and Immunogenicity of a Zoster Vaccine in SLE
https://clinicaltrials.gov/ct2/show/NCT02477150

Sep 4th, 2019 - Herpes zoster (HZ) (Shingles) is a painful condition caused by reactivation of varicella zoster virus (VZV) that remains dormant after primary infection. HZ reactivation may cause significant morbidity such as post-herpetic neuralgia and even mort...

Burden of Herpes Zoster and Post-herpetic Neuralgia Among People ≥ 50 Years Old in France
https://clinicaltrials.gov/ct2/show/NCT02487472

Sep 4th, 2019 - An observational, prospective cohort study of patients ≥ 50 years old with a Herpes Zoster (HZ) diagnosis, carried out by a national random sample of community first line practitioners concerned by HZ diagnosis: general practitioners, dermatologis...

see more →

News  317 results

Acute Non-PHN Complications of Herpes Zoster
https://www.medscape.com/viewarticle/941590

Nov 25th, 2020 - Acute complications of herpes zoster (HZ) other than post-herpetic neuralgia (PHN) are relatively common, a new study suggests. Researchers conducted a cohort study of unvaccinated immunocompetent adults with incident HZ (n=178,964) and matched to...

Debate: After Methotrexate Failure, Is JAK Inhibitor or Biologic Next?
https://www.medscape.com/viewarticle/941432

Nov 23rd, 2020 - What is the next step in treatment after a person with rheumatoid arthritis fails to adequately respond to methotrexate — a Janus kinase (JAK) inhibitor or a biologic? That was the focus of a lively debate at the virtual annual meeting of the Amer...

Upadacitinib Safety Similar to Other JAK Inhibitors for Rheumatoid Arthritis
https://www.medscape.com/viewarticle/940900

Nov 13th, 2020 - (Reuters Health) - A once-daily 15 mg dose of upadacitinib for rheumatoid arthritis has similar rates of malignancies, serious infections, major adverse cardiovascular events, and venous thromboembolic events as other Janus kinase (JAK) inhibitors...

Shingrix Effective in Older Adults With Preexisting Immune-Mediated Disorders
https://www.staging.medscape.com/viewarticle/938663

Oct 6th, 2020 - The adjuvanted recombinant zoster vaccine Shingrix appears to be effective in older adults with autoimmune diseases who are not receiving treatment regimens that suppress the immune system, according to a post hoc analysis of patients in two clini...

A Man With Skin Plaques Has Severe Pain After Eating
https://reference.medscape.com/viewarticle/884106_6

Sep 25th, 2020 - Question 1 of 2 Which of the following laboratory tests has the highest sensitivity, provides rapid results, and can be used to monitor treatment response when collected serially in patients with suspected herpes zoster? Your Peers Chose: VZV IgG ...

see more →

Patient Education  6 results see all →